(Q35029699)

5 August 2017

1 reference

title

Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents (English)

1 reference

5 August 2017

Ka Fai Chung

1

1 reference

5 August 2017

Claire K Y Lee

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

General Hospital Psychiatry

5 August 2017

published in

1 reference

5 August 2017

volume

24

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

430-435

1 reference

Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders--recognition, epidemiology, and rational management

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Epidemiology of alcohol and medication as aids to sleep in early adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Insomnia and its treatment. Prevalence and correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Over-the-counter sleep aids: widely used but rarely studied

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Psychotropic medication consumption patterns in the UK general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Review of randomised controlled trials of traditional Chinese medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Aqueous extract of valerian reduces latency to fall asleep in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Effect of valerian on human sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Double blind study of a valerian preparation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

The scientific basis for the reputed activity of Valerian

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Central nervous depressant activity of valerenic Acid in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Hepatotoxicity of herbal remedies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Cardiac complications and delirium associated with valerian root withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Valerian for insomnia: a systematic review of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Kava and dopamine antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Neurological manifestations of kava intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Coma from the health food store: interaction between kava and alprazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Herbal remedies in psychiatric practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Melatonin and insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Improvement of sleep quality in elderly people by controlled-release melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Melatonin replacement therapy of elderly insomniacs.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Clinical perspectives for melatonin and its agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Pro-convulsant effects of oral melatonin in neurologically disabled children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

Melatonin and fragmented sleep patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

A critical evaluation of the hypnotic efficacy of melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

A review of randomized, controlled clinical trials in acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900210-4

7 January 2021

10.1016/S0163-8343(02)00210-4

Identifiers

DOI

1 reference

5 August 2017

1 reference